144.04
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$144.12
Offen:
$143.41
24-Stunden-Volumen:
3.26M
Relative Volume:
0.62
Marktkapitalisierung:
$229.94B
Einnahmen:
$109.29B
Nettoeinkommen (Verlust:
$14.90B
KGV:
16.31
EPS:
8.83
Netto-Cashflow:
$20.03B
1W Leistung:
-3.01%
1M Leistung:
+2.54%
6M Leistung:
+9.38%
1J Leistung:
+43.05%
Morgan Stanley Stock (MS) Company Profile
Firmenname
Morgan Stanley
Sektor
Branche
Telefon
212-761-4000
Adresse
1585 BROADWAY, NEW YORK, NY
Vergleichen Sie MS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MS
Morgan Stanley
|
144.04 | 231.12B | 109.29B | 14.90B | 20.03B | 8.83 |
![]()
GS
Goldman Sachs Group Inc
|
715.95 | 221.28B | 125.66B | 15.56B | 66.86B | 45.38 |
![]()
SCHW
Charles Schwab Corp
|
95.82 | 174.57B | 26.67B | 7.28B | 39.40B | 3.72 |
![]()
HOOD
Robinhood Markets Inc
|
106.30 | 102.22B | 3.59B | 1.79B | 876.00M | 0.96 |
![]()
LPLA
Lpl Financial Holdings Inc
|
361.24 | 28.40B | 14.13B | 1.12B | 45.45M | 14.62 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-09 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
2024-11-26 | Herabstufung | HSBC Securities | Buy → Hold |
2024-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
2024-10-04 | Hochstufung | HSBC Securities | Hold → Buy |
2024-09-11 | Herabstufung | Goldman | Buy → Neutral |
2024-08-02 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
2024-07-17 | Herabstufung | Oppenheimer | Outperform → Perform |
2024-01-17 | Herabstufung | JP Morgan | Overweight → Neutral |
2024-01-17 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
2024-01-09 | Herabstufung | HSBC Securities | Buy → Hold |
2023-11-28 | Herabstufung | Societe Generale | Buy → Hold |
2023-11-20 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
2023-10-23 | Herabstufung | Odeon | Buy → Hold |
2023-10-20 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
2023-10-11 | Herabstufung | UBS | Buy → Neutral |
2023-09-07 | Eingeleitet | HSBC Securities | Buy |
2023-07-12 | Hochstufung | Odeon | Hold → Buy |
2023-01-18 | Herabstufung | Citigroup | Buy → Neutral |
2023-01-10 | Hochstufung | Odeon | Sell → Hold |
2023-01-04 | Herabstufung | Wolfe Research | Outperform → Underperform |
2022-10-05 | Herabstufung | Atlantic Equities | Overweight → Neutral |
2022-09-06 | Herabstufung | Odeon | Hold → Sell |
2022-05-03 | Hochstufung | Oppenheimer | Perform → Outperform |
2022-01-28 | Herabstufung | Odeon | Buy → Hold |
2021-12-03 | Hochstufung | Citigroup | Neutral → Buy |
2021-10-15 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2021-10-04 | Bestätigt | Jefferies | Buy |
2021-09-29 | Herabstufung | Oppenheimer | Outperform → Perform |
2021-09-28 | Herabstufung | Berenberg | Buy → Hold |
2021-08-13 | Herabstufung | Seaport Global Securities | Buy → Neutral |
2021-07-07 | Fortgesetzt | Keefe Bruyette | Outperform |
2021-06-09 | Eingeleitet | Jefferies | Buy |
2021-04-21 | Hochstufung | Berenberg | Hold → Buy |
2021-03-02 | Hochstufung | Daiwa Securities | Neutral → Outperform |
2021-01-06 | Eingeleitet | Daiwa Securities | Neutral |
2021-01-04 | Hochstufung | Barclays | Equal Weight → Overweight |
2020-11-10 | Herabstufung | Citigroup | Buy → Neutral |
2020-10-13 | Fortgesetzt | JP Morgan | Overweight |
2020-07-08 | Eingeleitet | Seaport Global Securities | Buy |
2020-06-24 | Hochstufung | DA Davidson | Neutral → Buy |
2020-06-23 | Bestätigt | UBS | Buy |
2020-05-21 | Hochstufung | Odeon | Hold → Buy |
2020-04-14 | Hochstufung | Societe Generale | Sell → Buy |
2020-03-13 | Hochstufung | Goldman | Neutral → Buy |
2020-03-04 | Hochstufung | Citigroup | Neutral → Buy |
2020-02-21 | Herabstufung | DA Davidson | Buy → Neutral |
2020-02-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2020-01-21 | Herabstufung | Citigroup | Buy → Neutral |
2020-01-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
2020-01-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
2020-01-09 | Eingeleitet | DA Davidson | Buy |
2020-01-06 | Herabstufung | Deutsche Bank | Buy → Hold |
2019-10-29 | Herabstufung | Odeon | Buy → Hold |
2019-10-10 | Hochstufung | Sandler O'Neill | Hold → Buy |
2019-07-12 | Hochstufung | Citigroup | Neutral → Buy |
2019-04-18 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Morgan Stanley Aktie (MS) Neueste Nachrichten
Morgan Stanley rates TLC as Equal-weight - MarketScreener
All Eyes on Nvidia Stock Ahead of Earnings; Here’s What Morgan Stanley Expects - TipRanks
Insmed stock price target raised to $144 from $126 at Morgan Stanley - Investing.com
Morgan Stanley Reiterates a Buy Rating on Nu Holdings Ltd. (NU) With an $18 PT - MSN
Healthcare Tech Leader Penumbra Scheduled for Wells Fargo and Morgan Stanley September Conferences - Stock Titan
Outset Medical to Present at 23rd Annual Morgan Stanley Global Healthcare Conference on September 10, 2025 - Quiver Quantitative
Industrial Tech Leader Kennametal ($2B Revenue) to Present at Morgan Stanley Laguna Conference - Stock Titan
Morgan Stanley Analyst Boosts NIO Stock Target to $6.50 on Restructuring Wins and Onvo Momentum - TipRanks
Lowe's (LOW) PT Raised to $270 at Morgan Stanley - StreetInsider
Form 424B2 MORGAN STANLEY - StreetInsider
This Auto Stock Gained 32% In One Year And Just Received A Morgan Stanley Price Target Hike – Find Out More - Stocktwits
Morgan Stanley Investment Management’s 1GT Invests in Series C Funding for Overhaul Group - citybiz
Morgan Stanley raises NIO stock price target to $6.50 on restructuring efforts - Investing.com
Nio price target raised to $6.50 from $5.90 at Morgan Stanley - TipRanks
Morgan Stanley Raises Nio’s Price Target, Sees 28% Upside Potential - eletric-vehicles.com
UnitedHealth's Turnaround Could Take Longer Than Expected, Morgan Stanley Says - 富途牛牛
NIO (NIO) PT Raised to $6.50 at Morgan Stanley - StreetInsider
Addiction Treatment Leader Indivior Sets Two Major September Investor Conference Appearances - Stock Titan
This is Why Morgan Stanley (MS) is a Great Dividend Stock - Yahoo Finance
Coupang's Growing Taiwan Business to Drive Long-term Growth, Morgan Stanley Says - MarketScreener
Viking Poised to See Increased Capacity in 2026, Morgan Stanley Says - MarketScreener
Morgan Stanley Forecasts Strong Price Appreciation for Willis Towers Watson Public (NASDAQ:WTW) Stock - MarketBeat
Morgan Stanley Boosts Prudential Financial (NYSE:PRU) Price Target to $117.00 - MarketBeat
CSI 300 could rally further despite testing 10-year highs: Morgan Stanley - StreetInsider
Morgan Stanley Increases Matador Resources (NYSE:MTDR) Price Target to $62.00 - MarketBeat
Morgan Stanley Issues Positive Forecast for Hamilton Insurance Group (NYSE:HG) Stock Price - MarketBeat
Morgan Stanley Lowers Marsh & McLennan Companies (NYSE:MMC) Price Target to $220.00 - MarketBeat
Morgan Stanley Lowers Equitable (NYSE:EQH) Price Target to $67.00 - MarketBeat
Lincoln National (NYSE:LNC) Stock Price Expected to Rise, Morgan Stanley Analyst Says - MarketBeat
Chubb (NYSE:CB) Given New $295.00 Price Target at Morgan Stanley - MarketBeat
Assurant (NYSE:AIZ) Given New $230.00 Price Target at Morgan Stanley - MarketBeat
Morgan Stanley Investment Management's 1GT Joins $105 Million Series C Funding for Overhaul Group - MarketScreener
Honeywell executives to speak at Jefferies, Morgan Stanley conferences (HON:NASDAQ) - Seeking Alpha
Wellington Management Group LLP Sells 1,590,941 Shares of Morgan Stanley $MS - MarketBeat
Coupang stock price target raised to $35 from $32 at Morgan Stanley - Investing.com
Morgan Stanley on Target (TGT): 'Will take a couple of quarters to gain clarity' - StreetInsider
Aptus Capital Advisors LLC Has $25.78 Million Stock Holdings in Morgan Stanley $MS - MarketBeat
AI-Powered Drug Discovery Company Absci Announces Major Healthcare Conference Appearances in September - Stock Titan
Meta Platforms (META) Receives a Buy from Morgan Stanley - The Globe and Mail
UnitedHealth price target lowered to $325 from $342 at Morgan Stanley - TipRanks
Granite Harbor Advisors Inc. Takes $202,000 Position in Morgan Stanley $MS - MarketBeat
Northern Trust Corp Grows Stake in Morgan Stanley $MS - MarketBeat
Coupang Inc (CPNG) PT Raised to $35 at Morgan Stanley - StreetInsider
Morgan Stanley $MS Shares Sold by Brooklyn Investment Group - MarketBeat
Morgan Stanley Raises Price Target on FTAI Aviation to $175 From $138, Keeps Overweight Rating - MarketScreener
Morgan Stanley Lifts Price Target on Amer Sports to $34 From $33, Keeps Equalweight Rating - MarketScreener
Morgan Stanley Lifts Price Target on Coupang to $35 From $32, Keeps Overweight Rating - MarketScreener
Nations Financial Group Inc. IA ADV Purchases 3,655 Shares of Morgan Stanley $MS - MarketBeat
Morgan Stanley Adjusts Price Target on Home Depot to $430 From $415, Maintains Overweight Rating - MarketScreener
Morgan Stanley Adjusts PT on UnitedHealth Group to $325 From $342, Maintains Overweight Rating - MarketScreener
Nice (NASDAQ:NICE) Price Target Lowered to $193.00 at Morgan Stanley - MarketBeat
Finanzdaten der Morgan Stanley-Aktie (MS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):